117 related articles for article (PubMed ID: 9679945)
21. Clinical and screening implications of the I1307K adenomatous polyposis coli gene variant in Israeli Ashkenazi Jews with familial colorectal neoplasia. Evidence for a founder effect.
Rozen P; Naiman T; Strul H; Taussky P; Karminsky N; Shomrat R; Samuel Z; Yaron Y; Orr-Urtreger A
Cancer; 2002 May; 94(10):2561-8. PubMed ID: 12173321
[TBL] [Abstract][Full Text] [Related]
22. The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect.
Shtoyerman-Chen R; Friedman E; Figer A; Carmel M; Patael Y; Rath P; Fidder HH; Bar-Meir S; Theodor L
Genet Test; 2001; 5(2):141-6. PubMed ID: 11551102
[TBL] [Abstract][Full Text] [Related]
23. Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development.
Koren-Michowitz M; Friedman E; Gershoni-Baruch R; Brok-Simoni F; Patael Y; Rechavi G; Amariglio N
Am J Hematol; 2005 Mar; 78(3):203-6. PubMed ID: 15726604
[TBL] [Abstract][Full Text] [Related]
24. Phenotypic characteristics associated with the APC gene I1307K mutation in Ashkenazi Jewish patients with colorectal polyps.
Syngal S; Schrag D; Falchuk M; Tung N; Farraye FA; Chung D; Wright M; Whetsell A; Miller G; Garber JE
JAMA; 2000 Aug; 284(7):857-60. PubMed ID: 10938175
[TBL] [Abstract][Full Text] [Related]
25. The I1307K polymorphism of the APC gene in colorectal cancer.
Prior TW; Chadwick RB; Papp AC; Arcot AN; Isa AM; Pearl DK; Stemmermann G; Percesepe A; Loukola A; Aaltonen LA; De La Chapelle A
Gastroenterology; 1999 Jan; 116(1):58-63. PubMed ID: 9869603
[TBL] [Abstract][Full Text] [Related]
26. Phenotypic characteristics of colo-rectal cancer in I1307K APC germline mutation carriers compared with sporadic cases.
Figer A; Shtoyerman-Chen R; Tamir A; Geva R; Irmin L; Flex D; Theodor L; Sulkes A; Sadetzki S; Bar-Meir S; Friedman E
Br J Cancer; 2001 Nov; 85(9):1368-71. PubMed ID: 11720476
[TBL] [Abstract][Full Text] [Related]
27. Body mass, age, and the APC I1307K allele in Ashkenazi Jewish prostate cancer patients.
Lehrer S; McCurdy LD; Stock RG; Kornreich R; Stone NN; Eng C
Cancer Genet Cytogenet; 2000 Oct; 122(2):131-3. PubMed ID: 11106824
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of the I1307K APC gene variant in Israeli Jews of differing ethnic origin and risk for colorectal cancer.
Rozen P; Shomrat R; Strul H; Naiman T; Karminsky N; Legum C; Orr-Urtreger A
Gastroenterology; 1999 Jan; 116(1):54-7. PubMed ID: 9869602
[TBL] [Abstract][Full Text] [Related]
29. Common origin of the I1307K APC polymorphism in Ashkenazi and non-Ashkenazi Jews.
Patael Y; Figer A; Gershoni-Baruch R; Papa MZ; Risel S; Shtoyerman-Chen R; Karasik A; Theodor L; Friedman E
Eur J Hum Genet; 1999 Jul; 7(5):555-9. PubMed ID: 10439961
[TBL] [Abstract][Full Text] [Related]
30. A single nucleotide primer extension assay to detect the APC I1307K gene variant.
Murphy KM; Geiger T; Hafez MJ; Eshleman JR; Griffin CA; Berg KD
J Mol Diagn; 2003 Nov; 5(4):222-6. PubMed ID: 14573780
[TBL] [Abstract][Full Text] [Related]
31. Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population.
Simchoni S; Friedman E; Kaufman B; Gershoni-Baruch R; Orr-Urtreger A; Kedar-Barnes I; Shiri-Sverdlov R; Dagan E; Tsabari S; Shohat M; Catane R; King MC; Lahad A; Levy-Lahad E
Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3770-4. PubMed ID: 16537453
[TBL] [Abstract][Full Text] [Related]
32. The I1307K APC mutation in a high-risk clinic setting: a follow-up study.
Regev M; Barzilai SE; Figer A; Zidan J; Fidder HH; Friedman E
Clin Genet; 2005 Apr; 67(4):352-5. PubMed ID: 15733272
[TBL] [Abstract][Full Text] [Related]
33. APC I1307K and the risk of prostate cancer.
Poynter JN; Cooney KA; Bonner JD; White KA; Tomsho LP; Rennert G; Gruber SB
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):468-73. PubMed ID: 16537703
[TBL] [Abstract][Full Text] [Related]
34. Founder BRCA 1 and 2 mutations among a consecutive series of Ashkenazi Jewish ovarian cancer patients.
Tobias DH; Eng C; McCurdy LD; Kalir T; Mandelli J; Dottino PR; Cohen CJ
Gynecol Oncol; 2000 Aug; 78(2):148-51. PubMed ID: 10926794
[TBL] [Abstract][Full Text] [Related]
35. Carrier rate of APC I1307K is not increased in inflammatory bowel disease patients of Ashkenazi Jewish origin.
Silverberg MS; Clelland C; Murphy JE; Steinhart AH; McLeod RS; Greenberg GR; Cohen Z; Siminovitch KA
Hum Genet; 2001 Mar; 108(3):205-10. PubMed ID: 11354631
[TBL] [Abstract][Full Text] [Related]
36. Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism.
Gryfe R; Di Nicola N; Lal G; Gallinger S; Redston M
Am J Hum Genet; 1999 Feb; 64(2):378-84. PubMed ID: 9973276
[TBL] [Abstract][Full Text] [Related]
37. Colorectal polyps in carriers of the APC I1307K polymorphism.
Rennert G; Almog R; Tomsho LP; Low M; Pinchev M; Chaiter Y; Bonner JD; Rennert HS; Greenson JK; Gruber SB
Dis Colon Rectum; 2005 Dec; 48(12):2317-21. PubMed ID: 16228836
[TBL] [Abstract][Full Text] [Related]
38. APC Asp1822Val and Gly2502Ser polymorphisms and risk of colorectal cancer and adenoma.
Tranah GJ; Giovannucci E; Ma J; Fuchs C; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):863-70. PubMed ID: 15824157
[TBL] [Abstract][Full Text] [Related]
39. Increased risk for familial ovarian cancer among Jewish women: a population-based case-control study.
Steinberg KK; Pernarelli JM; Marcus M; Khoury MJ; Schildkraut JM; Marchbanks PA
Genet Epidemiol; 1998; 15(1):51-9. PubMed ID: 9523210
[TBL] [Abstract][Full Text] [Related]
40. Gynecologic malignancies in Ashkenazi families with the MSH2 A636P founder mutation.
Lavie O; Gruber SB; Lejbkowicz F; Dishon S; Rennert G
Am J Obstet Gynecol; 2008 Aug; 199(2):148.e1-3. PubMed ID: 18674656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
